Komori
Tohoku Chemical (7446) · TargetRevenue Target Missed, Ordinary Profit Target Met

FY2020/9 targets: consolidated net sales of ¥31.7 billion and consolidated ordinary profit of ¥355 million

First written in FY2019. 2 of 4 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2020.

4entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020-Q2 – FY2020-Q32019: 12020: 32020
Same theme, other companies
Consolidated Earnings Forecast for the Fiscal Year Ending September 2020A theme 3 companies write about · 1 as a headwind · 0 as a tailwind

2 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2020Revenue Target Missed, Ordinary Profit Target MetAnnual report

    「As a result, compared with the same period of the previous year, net sales increased by ¥26 million, or 0.1%, to ¥31.040 billion; operating profit increased by ¥77 million, or 27.5%, to ¥361 million; and ordinary profit increased by ¥80 million, or 24.5%, to ¥410 million.」

    Against the FY2020/9 consolidated net sales target of ¥31.7 billion, actual net sales were ¥31.040 billion, falling short of the target. Meanwhile, against the consolidated ordinary profit target of ¥355 million, actual ordinary profit was ¥410 million, exceeding the target.
  2. FY2020-Q3AdvancedAnnual report

    「As a result, compared with the same quarter of the previous year, net sales increased by ¥100 million, or 0.4%, to ¥22,739 million; operating income increased by ¥55 million, or 36.8%, to ¥206 million; ordinary income increased by ¥64 million, or 34.8%, to ¥250 million; and net income attributable to owners of the parent increased by ¥172 million, or 153.7%, to ¥284 million, due to gains on sales of investment securities and other factors.」

    Against the FY2020/9 targets of consolidated net sales of ¥31.7 billion and consolidated ordinary profit of ¥355 million, cumulative results through the third quarter were net sales of ¥22.739 billion and ordinary profit of ¥250 million. Net sales and profit both increased year on year, and results toward the targets progressed.
  3. FY2020-Q2AdvancedAnnual report

    「However, compared with the same quarter of the previous year, net sales decreased by ¥143 million, or 0.9%, to ¥15,320 million; operating income decreased by ¥12 million, or 8.1%, to ¥143 million; ordinary income decreased by ¥9 million, or 5.2%, to ¥165 million; and net income attributable to owners of the parent decreased by ¥10 million, or 9.3%, to ¥100 million.」

    Against the FY2020/9 targets of consolidated net sales of ¥31.7 billion and consolidated ordinary profit of ¥355 million, cumulative results for the second quarter were net sales of ¥15.320 billion and ordinary profit of ¥165 million.
  4. FY2019First statedAnnual report

    「The company’s management policy is to meet shareholders’ expectations and achieve further profit growth, and it has established the following management targets for FY2020/9. Target achievement period: FY2020/9 Consolidated net sales: ¥31.7 billion Consolidated ordinary profit: ¥355 million」

    The company has set consolidated net sales of ¥31.7 billion and consolidated ordinary profit of ¥355 million as new management targets for FY2020/9.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Tohoku Chemical's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.